Trevena Inc

NASDAQ:TRVN 3:59:48 PM EDT

0.41

0.00 (+0.46%)

: $0.40 -0.02 (-3.74%)

Market Cap (Intraday)	68.61M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.36 Million
Adjusted EPS	-$0.10

See more estimates

10-Day MA	$0.42
50-Day MA	$0.33
200-Day MA	$0.62

See more pivots

Trevena Inc Stock, NASDAQ:TRVN

955 Chesterbrook Boulevard, Suite 110, Chesterbrook, Pennsylvania 19087

United States of America

Phone: +1.610.354.8840

Number of Employees: 43

http://www.trevenainc.com

Description

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.